Jonathan Montagu is Vice President, Business Operations at Nimbus Discovery and an Entrepreneur-in-Residence at Atlas Venture. Prior to joining Nimbus, Jonathan led Business Development at Concert Pharmaceuticals where he was responsible for Licensing and Corporate Strategy. In 2009, Jonathan was instrumental in securing a multi-product collaboration with GlaxoSmithKline with potential milestones exceeding $1B. Jonathan was also responsible for commercial decision making for three clinical-stage products now in the company’s pipeline. Jonathan joined Concert from Johnson & Johnson where he served on the launch teams for two antibiotics, doripenem and ceftobiprole. Prior to J&J, Jonathan was an Associate at the Boston Consulting Group where he served multi-national pharmaceutical companies. Mr. Montagu received a Masters in Chemistry at Oxford University in the U.K., and an M.B.A. from Stanford Graduate School of Business.